Biologic Drugs

Aug 30, 2017
By Pharmaceutical Technology Editors
FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.
Aug 29, 2017
By Pharmaceutical Technology Editors
AstraZeneca and Takeda will partner to develop and commercialize MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD).
Aug 29, 2017
By Pharmaceutical Technology Editors
Gilead will gain a robust pipeline of cell therapy products, with one lead candidate, a CAR T therapy, anticipated to gain FDA approval in the fourth quarter.
Aug 24, 2017
By Pharmaceutical Technology Editors
With £4.5 million (US$5.8 million) in funding, the consortium is tasked with developing a new automated continuous biologics purification unit to make biologic drug manufacturing more efficient.
Aug 24, 2017
By Pharmaceutical Technology Editors
FDA grants priority review for emicizumab, an investigational bispecific monoclonal antibody, for treating hemophilia A with factor VIII inhibitors.
Aug 21, 2017
By Pharmaceutical Technology Editors
The first program of this collaboration will focus on the development of a candidate for severe acute pancreatitis.
Aug 18, 2017
By Pharmaceutical Technology Editors
The withdrawal has been attributed to issues at the biotech company’s manufacturing facility.
Aug 18, 2017
By Pharmaceutical Technology Editors
FDA approves new molecular entity developed by Pfizer for treating a rare form of leukemia in adults.
Aug 15, 2017
By Pharmaceutical Technology Editors
The antibody therapeutic failed to meet its primary endpoint in a Phase III study.
Aug 07, 2017
By Pharmaceutical Technology Editors
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline.
native1_300x100
lorem ipsum